nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—Abdominal pain upper—Mitoxantrone—sarcoma	0.0286	0.0286	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Thiotepa—sarcoma	0.0218	0.0218	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Thiotepa—sarcoma	0.0175	0.0175	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Thiotepa—sarcoma	0.0157	0.0157	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Vincristine—sarcoma	0.0155	0.0155	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Thiotepa—sarcoma	0.0155	0.0155	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Thiotepa—sarcoma	0.0154	0.0154	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Dactinomycin—sarcoma	0.0154	0.0154	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Thiotepa—sarcoma	0.0154	0.0154	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Dactinomycin—sarcoma	0.0152	0.0152	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Thiotepa—sarcoma	0.0146	0.0146	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Dactinomycin—sarcoma	0.0145	0.0145	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Thiotepa—sarcoma	0.0141	0.0141	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Dactinomycin—sarcoma	0.014	0.014	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Vincristine—sarcoma	0.0137	0.0137	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vincristine—sarcoma	0.0136	0.0136	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vincristine—sarcoma	0.0136	0.0136	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Mitoxantrone—sarcoma	0.0135	0.0135	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Mitoxantrone—sarcoma	0.0134	0.0134	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—sarcoma	0.0133	0.0133	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Mitoxantrone—sarcoma	0.0133	0.0133	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Vincristine—sarcoma	0.0129	0.0129	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Thiotepa—sarcoma	0.0128	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Dactinomycin—sarcoma	0.0127	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0126	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Vincristine—sarcoma	0.0125	0.0125	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—sarcoma	0.0123	0.0123	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Thiotepa—sarcoma	0.0122	0.0122	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Mitoxantrone—sarcoma	0.0122	0.0122	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Dactinomycin—sarcoma	0.0121	0.0121	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Thiotepa—sarcoma	0.0118	0.0118	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Vincristine—sarcoma	0.0113	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Thiotepa—sarcoma	0.0113	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Dactinomycin—sarcoma	0.0112	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Thiotepa—sarcoma	0.0112	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Thiotepa—sarcoma	0.0112	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Thiotepa—sarcoma	0.0112	0.0112	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Dactinomycin—sarcoma	0.0111	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Etoposide—sarcoma	0.0111	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Etoposide—sarcoma	0.011	0.011	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Mitoxantrone—sarcoma	0.011	0.011	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Etoposide—sarcoma	0.011	0.011	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Vincristine—sarcoma	0.0108	0.0108	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Thiotepa—sarcoma	0.0106	0.0106	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Mitoxantrone—sarcoma	0.0105	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Dactinomycin—sarcoma	0.0105	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Etoposide—sarcoma	0.0105	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Vincristine—sarcoma	0.0104	0.0104	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Etoposide—sarcoma	0.0101	0.0101	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Vincristine—sarcoma	0.01	0.01	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Vincristine—sarcoma	0.00996	0.00996	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vincristine—sarcoma	0.00995	0.00995	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vincristine—sarcoma	0.00989	0.00989	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Mitoxantrone—sarcoma	0.00978	0.00978	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Mitoxantrone—sarcoma	0.0097	0.0097	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Mitoxantrone—sarcoma	0.00969	0.00969	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Mitoxantrone—sarcoma	0.00964	0.00964	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Vincristine—sarcoma	0.00938	0.00938	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Etoposide—sarcoma	0.00918	0.00918	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Mitoxantrone—sarcoma	0.00914	0.00914	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—sarcoma	0.00879	0.00879	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Etoposide—sarcoma	0.00875	0.00875	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—sarcoma	0.00866	0.00866	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Etoposide—sarcoma	0.00846	0.00846	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Etoposide—sarcoma	0.00813	0.00813	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—sarcoma	0.00813	0.00813	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Etoposide—sarcoma	0.00807	0.00807	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Etoposide—sarcoma	0.00806	0.00806	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Etoposide—sarcoma	0.00802	0.00802	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—sarcoma	0.00801	0.00801	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Etoposide—sarcoma	0.0076	0.0076	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—sarcoma	0.00703	0.00703	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—sarcoma	0.00651	0.00651	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—sarcoma	0.00631	0.00631	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—sarcoma	0.00623	0.00623	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—sarcoma	0.00619	0.00619	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—sarcoma	0.00618	0.00618	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—sarcoma	0.00586	0.00586	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—sarcoma	0.00584	0.00584	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—sarcoma	0.00577	0.00577	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00573	0.00573	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—sarcoma	0.00572	0.00572	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—sarcoma	0.00567	0.00567	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—sarcoma	0.00543	0.00543	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—sarcoma	0.00525	0.00525	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—sarcoma	0.00515	0.00515	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—sarcoma	0.00491	0.00491	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—sarcoma	0.00476	0.00476	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—sarcoma	0.00474	0.00474	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—sarcoma	0.00456	0.00456	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—sarcoma	0.00454	0.00454	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Epirubicin—sarcoma	0.00452	0.00452	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—sarcoma	0.00452	0.00452	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—sarcoma	0.00449	0.00449	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—sarcoma	0.00439	0.00439	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Epirubicin—sarcoma	0.00426	0.00426	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—sarcoma	0.00422	0.00422	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—sarcoma	0.00418	0.00418	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—sarcoma	0.00418	0.00418	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Doxorubicin—sarcoma	0.00416	0.00416	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—sarcoma	0.00394	0.00394	CcSEcCtD
